These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5822586)

  • 21. Biochemical and biophysical conditions for blood clot lysis.
    Sabovic M; Blinc A
    Pflugers Arch; 2000; 440(5 Suppl):R134-6. PubMed ID: 11005642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purification and characterization of placental plasminogen activator (PPA).
    Kobayashi T; Terao T
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 May; 37(5):783-92. PubMed ID: 3923141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Purification and biochemical character of a fibrinolytic protein from Eupolyphaga sinensis].
    Han YL; Li ZW
    Sheng Wu Gong Cheng Xue Bao; 2006 Jul; 22(4):639-43. PubMed ID: 16894902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasminogen activation and lysis of blood clots induced by cells in vitro.
    Knox P; Crooks S
    J Cell Physiol; 1988 Jun; 135(3):467-73. PubMed ID: 2456288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification and characterization of the plasminogen activator secreted by a rat brain tumor cell line in culture.
    Bykowska K; Rijken DC; Collen D
    Thromb Haemost; 1981 Oct; 46(3):642-4. PubMed ID: 7198301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Index of fibrinolysis with new fibrin plate (author's transl)].
    Hishikawa Y; Sugie I
    Nihon Seirigaku Zasshi; 1977; 39(1):1-11. PubMed ID: 140239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma tissue-type plasminogen activator increases fibrinolytic activity of exogenous urokinase-type plasminogen activator.
    Shenkman B; Livnat T; Budnik I; Tamarin I; Einav Y; Martinowitz U
    Blood Coagul Fibrinolysis; 2012 Dec; 23(8):729-33. PubMed ID: 22918041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Characterization of urokinase type plasminogen activator modified by phenylglyoxal].
    Mukhametova LI; Aĭsina RB; Lomakina GIu; Varfolomeev SD
    Bioorg Khim; 2002; 28(4):308-14. PubMed ID: 12197387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins.
    Toki N; Sumi H; Sasaki K; Boreisha I; Robbins KC
    J Clin Invest; 1985 Apr; 75(4):1212-22. PubMed ID: 3921568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation of plasminogen activator from vascular trees of human cadavers. Its comparison with urokinase.
    Aoki N
    J Biochem; 1974 Apr; 75(4):731-41. PubMed ID: 4847212
    [No Abstract]   [Full Text] [Related]  

  • 31. Whole blood clot lysis in newborns and adults after adding different concentrations of recombinant tissue plasminogen activator (Rt-PA).
    Trusen B; Ries M; Zenker M; Rauh M; Beinder E; Keuper H; Harms D
    Semin Thromb Hemost; 1998; 24(6):599-604. PubMed ID: 10066156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.
    Collen D; De Cock F; Demarsin E; Lijnen HR; Stump DC
    Thromb Haemost; 1986 Aug; 56(1):35-9. PubMed ID: 3095946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Receptor mediated binding of the fibrinolytic components, plasminogen and urokinase, to peripheral blood cells.
    Miles LA; Plow EF
    Thromb Haemost; 1987 Oct; 58(3):936-42. PubMed ID: 2829380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasminogen and urokinase determination based on the lysis time method. Purification of the substrates--kinetic and methodological studies.
    Berg W
    Acta Med Scand Suppl; 1967; 478():1-45. PubMed ID: 4231608
    [No Abstract]   [Full Text] [Related]  

  • 35. [Inactivation and stabilization of urokinase fibrinolytic activity in vitro].
    Aĭsina RB; Mukhametova LI; Sazonova IIu; Varfolomeev SD
    Bioorg Khim; 1998 Jul; 24(7):544-8. PubMed ID: 9749317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of action of fibrinolytic enzymes in vivo.
    Ambrus JL; Weber FJ; Ambrus CM
    J Med; 1979; 10(1-2):99-119. PubMed ID: 158624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of fibrinolysis in vitro by ultrasound.
    Francis CW; Onundarson PT; Carstensen EL; Blinc A; Meltzer RS; Schwarz K; Marder VJ
    J Clin Invest; 1992 Nov; 90(5):2063-8. PubMed ID: 1430229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound: comparison of nine plasminogen activators in vitro.
    Sakharov DV; Barrertt-Bergshoeff M; Hekkenberg RT; Rijken DC
    Thromb Haemost; 1999 Apr; 81(4):605-12. PubMed ID: 10235448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibrinolytic activity of immobilized plasminogen activator.
    Senatore FF; Bernath FR
    Res Commun Chem Pathol Pharmacol; 1985 Aug; 49(2):295-304. PubMed ID: 4059655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions of fibrinolytic system proteins with lysine-containing surfaces.
    McClung WG; Clapper DL; Anderson AB; Babcock DE; Brash JL
    J Biomed Mater Res A; 2003 Sep; 66(4):795-801. PubMed ID: 12926031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.